Screener
Bioventus BVS Deferred Finance Costs Net
Deferred Finance Costs Net at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:DeferredFinanceCostsNet.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
FAQ
- What is Bioventus's deferred finance costs net?
- Bioventus (BVS) reported deferred finance costs net of $508K in Q2 2026.
- How has Bioventus's deferred finance costs net changed year-over-year?
- Bioventus's deferred finance costs net decreased by 39.1% year-over-year, from $834K to $508K.
- What is the long-term trend for Bioventus's deferred finance costs net?
- Over 5 years (2020 to 2025), Bioventus's deferred finance costs net has grown at a -12.3% compound annual growth rate (CAGR), from $1.1M to $570K.
- What does deferred finance costs net mean?
- Deferred Finance Costs Net as reported by Bioventus Inc. Class A Common Stock.
Ask your AI about Bioventus's deferred finance costs net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude